Cargando…
Inhibitory effect of CUL1 on atherosclerosis through the p53 pathway
BACKGROUND: Atherosclerosis (AS) is a serious chronic condition associated with cardiovascular and cerebrovascular diseases. Research on AS is currently lacking, and there is a need to increase research to improve the diagnosis, treatment, and prognosis of AS. Therefore, the aim of the present study...
Autores principales: | Zhang, Xi, Lu, Youwei, Jiang, Wei, Yang, Qianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577759/ https://www.ncbi.nlm.nih.gov/pubmed/36267727 http://dx.doi.org/10.21037/atm-22-4372 |
Ejemplares similares
-
The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis
por: Lu, Youwei, et al.
Publicado: (2021) -
Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes
por: Yu, Qing, et al.
Publicado: (2020) -
Skp1 Independent Function of Cdc53/Cul1 in F-box Protein Homeostasis
por: Mathur, Radhika, et al.
Publicado: (2015) -
Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53
por: Li, Zhijun, et al.
Publicado: (2017) -
The Proto-Oncogene Int6 Is Essential for Neddylation of Cul1 and Cul3 in Drosophila
por: Rencus-Lazar, Sigal, et al.
Publicado: (2008)